125 MW Awarded in Ontario LT1 RFP: Boralex consolidates its position as a leading battery storage developer in Canada – Padovanews padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.
Boralex (TSE:BLX) Price Target Lowered to C$42.00 at Desjardins themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Boralex Inc. (TSE:BLX – Free Report) – Equities research analysts at Cormark issued their Q1 2024 EPS estimates for shares of Boralex in a report issued on Wednesday, May 1st. Cormark analyst N. Boychuk expects that the company will post earnings per share of $0.66 for the quarter. The consensus estimate for Boralex’s current full-year […]
Boralex Inc. (TSE:BLX) Receives Average Recommendation of "Buy" from Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Boralex Inc. (TSE:BLX) Receives Average Rating of "Buy" from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Desjardins Trims Boralex (TSE:BLX) Target Price to C$42.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Boralex Inc. (TSE:BLX – Free Report) – Raymond James cut their Q2 2024 EPS estimates for shares of Boralex in a research report issued on Thursday, April 25th. Raymond James analyst D. Quezada now forecasts that the company will post earnings per share of $0.06 for the quarter, down from their previous estimate of $0.11. […]
Investment Analysts’ price target changes for Thursday, April 25th: Acrivon Therapeutics (NASDAQ:ACRV) had its target price boosted by JMP Securities from $14.00 to $17.00. They currently have a market outperform rating on the stock. Align Technology (NASDAQ:ALGN) had its price target raised by Morgan Stanley from $344.00 to $360.00. The firm currently has an overweight […]